ICAgen Report issue

For profit Phase 3
Founded: Durham NC United States (1992)
Status: Acquired by Pfizer (2011)

Organization Overview

First Clinical Trial
2002
NCT00040677
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ICAgen

Active Ingredients

Drugs in Phase 3 Trials (1)

senicapoc (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 2)

Anemia, Sickle Cell (Phase 3)

Asthma (Phase 2)

Asthma, Exercise-Induced (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 1